accepted
on 27 Sep 2023
Last Applicant/ Owned by
855 N. Wolfe Street, Suite 621
Baltimore
MD
21205
Serial Number
87190457 filed on 01st Oct 2016
Registration Number
5320821 registered on 31st Oct 2017
Correspondent Address
Leonard D. Bowersox
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Development of pharmaceutical products for others; product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others Color is not claimed as a feature of the mark. pharmaceutical preparations and substances for the treatment of telomere-shortening diseases (e.g., dyskeratosis congenita, FancoRead More
Development of pharmaceutical products for others; product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others
19th May 2016
19th May 2016
pharmaceutical preparations and substances for the treatment of telomere-shortening diseases (e.g., dyskeratosis congenita, Fanconi anemia, idiopathic and pulmonary fibrosis), karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, cancer; chemicals and chemical preparations for medical and pharmaceutical purposes for telomere-shortening diseases (e.g., dyskeratosis congenita, and Fanconi anemia), idiopathic pulmonary fibrosis, karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, and cancers
19th May 2016
19th May 2016
No 87190457
No Service Mark
No 3190-258
No
No
No
No
No
No
No
No
26.05.28 -
Miscellaneous designs with overall triangular shape
The mark consists of a stylized triangular geometric shape and the stylized wording "ELIXIRGEN".
| Status Date | Action Taken |
|---|---|
| 27th Sep 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 27th Sep 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| 26th Sep 2023 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 23rd Aug 2023 | POST REGISTRATION ACTION MAILED - SEC. 8 |
| 22nd Aug 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 21st Mar 2023 | TEAS SECTION 8 RECEIVED |
| 17th Mar 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 17th Mar 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 17th Mar 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 17th Mar 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
